Miller David C, Saigal Christopher S, Litwin Mark S
Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Urol Clin North Am. 2009 Feb;36(1):11-27, v. doi: 10.1016/j.ucl.2008.08.004.
The National Institute of Diabetes and Digestive and Kidney Diseases initiated the Urologic Diseases in America project in 2001 with the goal of quantifying the immense demographic burden of urologic diseases on the American public, in both human and financial terms. This effort was renewed in 2007 with the aim of expanding and deepening analyses of the epidemiology, costs, and quality of medical care in urology. This ongoing commitment recognizes the major public health impact of urologic conditions in the United States. A thoughtful policy response to these changes requires a thorough understanding of the health care resource use and clinical epidemiology relevant to urologic diseases in America. This article details major initial findings from the Urologic Diseases in America project with respect to the demographic impact of the most common benign, malignant, and pediatric urologic conditions.
美国国立糖尿病、消化和肾脏疾病研究所于2001年启动了“美国泌尿系统疾病”项目,目的是从人力和财力两方面量化泌尿系统疾病给美国公众带来的巨大人口负担。2007年该项目再次启动,旨在扩大和深化对泌尿外科流行病学、成本及医疗质量的分析。这一持续的投入认识到泌尿系统疾病对美国主要公共卫生的影响。要对这些变化做出深思熟虑的政策回应,需要全面了解与美国泌尿系统疾病相关的医疗资源使用情况和临床流行病学。本文详细介绍了“美国泌尿系统疾病”项目关于最常见的良性、恶性及儿科泌尿系统疾病人口影响的主要初步研究结果。